Comparing the current results to its competitors, Arcadia Biosciences Inc reported Revenue decrease in the 2 quarter 2026 year on year by -0.82 %, slower than the combined decrease of the RKDA's competitors by -4.95 %, recorded in the same quarter.
Arcadia Biosciences Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 263.56 %
Arcadia Biosciences Inc 's Comment on Competition and Industry Peers
The markets for seed traits and agricultural biotechnology products are highly
competitive, and we face significant direct and indirect competition in several
aspects of our business. Competition for improving plant genetics comes from conventional
and advanced plant breeding techniques, as well as from the development of
advanced biotechnology traits. Other potentially competitive sources of improvement
in crop yields include improvements in crop protection chemicals, fertilizer formulations,
farm mechanization, other biotechnology, and information management. Programs
to improve genetics and chemistry are generally concentrated within a relatively
small number of large companies, while non-genetic approaches are underway with
broader set of companies.
In general, we believe that our competitors generally fall into the following
categories:
Large Agricultural Biotechnology, Seed, and Chemical Companies: According to Phillips
McDougall, the leading 11 seed and trait companies as a group invested $4.1 billion
in seed and trait research and development in 2013. This includes conventional
and advanced plant breeding, as well as biotechnology trait development. According
to Phillips McDougall, only a limited number of companies have been actively involved
in new trait discovery, development, and commercialization: Monsanto, DuPont Pioneer,
Syngenta, BASF, Bayer, Dow, KWS, and Genective (a joint venture between KWS and
Limagrain). Many of these companies have substantially larger budgets for gene
discovery, research, development, and product commercialization than we do. Some
of these companies also have substantial resources and experience managing the
regulatory process for new GM seed traits. Each of Monsanto, DuPont Pioneer, Syngenta,
Dow, and Bayer, which accounted for 85% of the 2013 seed trait research and development
spend noted above, also have significant chemical crop protection background and
businesses. The trait pipelines of these companies are heavily weighted toward
biotic stress traits, although they also have significant programs aimed at development
of abiotic stress traits. While these companies have internal programs that may
compete with our own, they also seek new traits externally and, as such, some
of them either currently are, or may in the future be, our collaborators. In addition,
some of these companies are currently among our sources for new trait technologies.
Trait Research and Development Companies: There are a number of companies that
specialize in research and development of agricultural yield and product quality
traits, and we believe that a dozen or more companies, including Evogene and Keygene,
among others, are competitors in our field. We believe that these companies typically
focus on a limited number of traits, and do not generally have the product development
and regulatory infrastructure necessary to bring traits to market. Therefore,
they typically license trait technologies to large industry players with in-house
development and regulatory capabilities at a relatively early stage of development.
Companies Focused on the Development and Commercialization of Microbial Crop Enhancements:
The use of microbial products to enhance crop performance via application to soil,
seed, or to crops directly is an area where increased research and development
activity has been underway for the past decade or more. We believe that there
are more than 20 companies of varying size working in this space. There have been
a number of acquisitions, including Becker Underwood by BASF, and joint collaborations
in this space, but multiple independent companies remain, including Verdesian,
Marrone Bioinnovations, Biagro and Bioconsortia. While these companies could be
considered to compete with us as their products seek to improve crop yields, we
believe that such products and our traits may be additive, or synergistic, to
our future products in terms of increasing crop yields.
Companies Focused on Farming Data Management, or Precision Agriculture: Within
the past several years there has been a rapid increase in technologies and companies
focused on acquiring, analyzing, and acting upon data in ways that may improve
farm economics via increased crop yield and more efficient management of crop
production inputs. Technical approaches include weather prediction and monitoring,
high-density field and crop imaging systems, precision field soil and yield mapping,
and others. Companies focusing on this space include Climate Corporation (acquired
by Monsanto), Farmers Business Network, Farmers Edge, Trimble, Planet Labs, Ceres
Imaging, Blue River Technologies, and others. While these products are potentially
competitive with us for increasing crop yields, we believe that certain of these
products could also be additive or synergistic with our traits.
Agricultural Research Universities and Institutions: Given the global importance
of agriculture, numerous agricultural research universities and institutions around
the world focus on basic and applied research aimed at increasing crop yield.
According to the Agricultural Science and Technology Indicators, global public
spending on agricultural research and development in 2008 totaled $31.7 billion,
having increased by 22% during the years from 2000 to 2008. Spending in 2008 in
high income countries accounted for approximately 51% of the total, while spending
in low and middle income countries accounted for 49% of the total. The United
States was the largest contributor of public agriculture funding in 2008 with
a total investment of $4.8 billion. Most of this publicly funded research is focused
on basic research. Many public research programs aim to understand basic biological
processes and do not necessarily engage in further development and commercialization
of discovered traits. While these programs are potentially competitive with us,
we view them primarily as sources of innovation that fit with our business model.
We have an established track record of working closely and effectively with public
research programs, including a number from the U.S., Canada, Japan, Australia,
Spain, Ireland, and elsewhere.
We believe that we are uniquely positioned at the nexus of basic research and
commercial product development. Unlike many companies in our space, we generally
do not compete in the area of basic research. Our focus is on development and
validation and, therefore, we provide a value-added link by which basic research
can be brought to market. While internal programs at the largest seed and technology
companies are competitive with ours in some cases, we are technology providers
to some of these companies, and we have numerous collaborations with many of them.
To remain competitive, we plan to pursue multiple strategies, including further
building our non-GM pipeline of new technologies from basic research programs,
increasing the scope and range of our field testing activities, and continuing
to protect our intellectual property rights in key jurisdictions globally.
despite revenue deterioration, Arcadia Biosciences Inc increased its market share in this segment. company increased its market share in this segment to approximately 0.01 %.
May 19, 2024
A Challenging Year for Arcadia Biosciences: Evaluating Recent Transactions and Comparing CompetitorsArcadia Biosciences, a prominent producer and marketer of plant-based health and wellness products, recently announced that it will be hosting an investor call to discuss its recent strategic transactions. The company has scheduled the call for May 22, 2024, after market close, providing analysts and investors an opportunity to gain insights into its future plans and performance.Examining the financial results of Arcadia Biosciences in the third quarter of 2023, a concerning revenue decrease of -14.96% was reported compared to the previous year. However, it is important to note that this decline was relatively...
May 14, 2024
In a strategic move to enhance its focus on plant-based health and wellness products, Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leading producer and marketer, has recently sold its non-GMO Resistant Starch (RS) Durum Wheat trait to its long-term partner, Corteva Agriscience. The agreement, which entails a $4 million deal, allows Arcadia to retain the rights to continue using Resistant Starch Durum in its GoodWheat portfolio. This groundbreaking development highlights Arcadia s commitment to innovative products while expanding its partnership with Corteva Agriscience.Arcadia Biosciences Pursuit of Plant-Based Health Solutions:Arcadia Biosciences is a renowned producer and marketer of plant-based health and...
American Vanguard Corporation is a specialty chemical manufacturer that operates through two segments - the Crop Protection segment, which develops and sells chemicals for crop protection, and the Other segment, which includes the marketing and distribution of agricultural, animal health, and consumer products. They focus on providing solutions to enhance agricultural productivity and sustainability while meeting the needs of their customers in various industries.
Mosaic Cos business model focuses on the production and distribution of fertilizers and crop nutrition solutions, primarily through the mining and manufacturing of phosphate and potash. The company operates globally, leveraging its expertise in fertilizer technology to meet the needs of agricultural customers while promoting sustainable farming practices.
Intrepid Potash Inc operates as a producer and distributor of potash and langbeinite, primarily used in fertilizer production. The company mines potash ore and processes it to produce multiple products for sale in the agriculture industry. Intrepid Potash Inc also provides water, solar, and power generation solutions to various industries, contributing to its diversified revenue streams.
Honeywell International Inc operates as a diversified technology and manufacturing company, providing a broad portfolio of products and solutions across multiple sectors including aerospace, buildings, materials, and safety. The company emphasizes innovation and efficiency, leveraging advanced technologies to enhance productivity and sustainability for its customers. By integrating software and hardware in its offerings, Honeywell aims to deliver comprehensive solutions that drive operational excellence and long-term growth.
Sources:
Arcadia Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Arcadia Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.